A Festschrift Celebrating Dr. Dimiter Stanchev Dimitrov: Antibodies, Innovation, and Impact on Infectious Disease and Cancer Research

Q: What does this research mean for the field?

Antibody therapeutics are increasingly being engineered rather than merely selected, with broad applications across oncology, infectious disease, and autoimmunity. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.NEUTRAL.

Ponraj Prabakaran; Tianlei Ying; Wei Li

doi:10.3390/antib15050078

September 1, 2026AntibodiesOpen Access

A Festschrift Celebrating Dr. Dimiter Stanchev Dimitrov: Antibodies, Innovation, and Impact on Infectious Disease and Cancer Research

View Full Paper

Ask AI

Bookmark

Share

Key Points

To commemorate the scientific contributions of Dr. Dimiter Stanchev Dimitrov and evaluate the evolution and clinical impact of engineered antibody therapeutics.
Commemorative synthesis reviewing milestones in antibody discovery, structural biology, and therapeutic innovation.
Qualitative assessment of shifts from traditional hybridoma and selection methods toward rational molecular antibody engineering.
Therapeutic antibody development has transitioned toward rational protein engineering to tailor affinity, stability, and effector functions for clinical applications.
Engineered antibody formats have established clinical utility across diverse therapeutic areas, particularly oncology, infectious diseases, and autoimmune disorders.

No abstract yet

We only have this paper's title and publication details.

Read it at the source

Implication

Review highlights advances in engineered antibody therapeutics across oncology and infectious diseases, indicating expanding opportunities for targeted clinical intervention.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Prabakaran et al. (2026) studied this question.

synapsesocial.com/papers/6a9935b1636c6408cfa7e2b8 https://doi.org/10.3390/antib15050078

View Full Paper

Ask AI

Bookmark

Share

A Festschrift Celebrating Dr. Dimiter Stanchev Dimitrov: Antibodies, Innovation, and Impact on Infectious Disease and Cancer Research

Key Points

No abstract yet

Implication

Discussion

Cite This Study

A Festschrift Celebrating Dr. Dimiter Stanchev Dimitrov: Antibodies, Innovation, and Impact on Infectious Disease and Cancer Research

Key Points

No abstract yet

Implication

Discussion

Cite This Study

Keep reading

More related papers

More from Antibodies

Keep reading

More related papers

More from Antibodies